Previous Close | 3.9820 |
Open | 4.0100 |
Bid | 3.8680 x 4120000 |
Ask | 3.8610 x 2611100 |
Day's Range | 3.8530 - 4.1620 |
52 Week Range | 3.8530 - 8.7720 |
Volume | |
Avg. Volume | 5,177,527 |
Market Cap | 6.361B |
Beta (5Y Monthly) | 1.42 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3200 |
Earnings Date | Oct 16, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.90 |
Nel Hydrogen Electrolyser AS, a fully owned subsidiary of Nel ASA (Nel) (OSE: NEL), has today been awarded a grant from the EU Innovation Fund of up to EUR 135 million for industrialization of its next-generation pressurized alkaline technology. The technology is currently being prototyped, and the potential industrialization is planned at Herøya, Norway.
Nel ASA (Nel) (OSE: NEL) reported revenues of NOK 366 million in the third quarter of 2024, up 21% from NOK 303 million in the same quarter last year. EBITDA in the quarter was NOK -90 million (Q3 2023: -62). The Alkaline segment contributed positively to Group EBITDA, but this was more than offset by the negative contribution from the PEM segment due to unusually low revenues in the quarter. Order intake was NOK 161 million (Q3 2023: 338 million). At the end of the quarter the order backlog was